📰 Mark Plavsic News
Mark Plavsic News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Mark Plavsic. Real-time updates on events, politics, business and more.
November 10, 2023
Received FDA Agreement Under Special Protocol Assessment (SPA) for the CoMpass Phase 3 Clinical TrialPositive Clinical Efficacy Updates of Bel-sar for Early-Stage Choroidal Melanoma from the Ongoing Phase 2 Clinical Trial with Suprachoroidal Administration Presented at AAO 2023Preliminary Data from Phase 1 Trial in...
November 9, 2023
Received FDA Agreement Under Special Protocol Assessment for the CoMpass Phase 3 Clinical Trial Positive Clinical Efficacy Updates of Bel-sar for Early-Stage Choroidal Melanoma from the Ongoing...
October 3, 2023
J. Jill Hopkins, M.D., Appointed as Chief Medical Officer and President of Research & DevelopmentMark Plavsic, Ph.D., Appointed as Chief Technology OfficerBOSTON--(BUSINESS WIRE)--Aura Biosciences Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate (VDC)...
October 2, 2023
By Oyin Adedoyin Aura Biosciences has appointed Dr. Jill Hopkins as chief medical officer and president of research and development. Mark Plavsic has also...